miR-30e-3p protects against coronary microembolism-induced cardiomyocyte pyroptosis and inflammation via the HDAC2/SMAD7 pathway.
promoter. miR-30e-3p, by binding HDAC2 to promote SMAD7 expression, reduces CME-induced cardiomyocyte pyroptosis and inflammation.
Dai et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: